Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients

Perfusion

Volumn 13, Issue 5, 1998, Pages 297-303

  Tigchelaar, Izaak ^a   Gallandat Huet, Rolf C G ^a   Boonstra, Piet W ^a   Van Oeveren, Willem ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLB; GELATIN; HETASTARCH; HUMAN ALBUMIN; PLASMA SUBSTITUTE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GELOPLASMA; HALF LIFE TIME; HEMODYNAMICS; HUMAN; MOLECULAR WEIGHT; ONCOTIC PRESSURE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031708973     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919801300503     Document Type: Article

References (24)

1. McGrath LB, Gonzalez-Lavin L, Neary MJ. Comparison of dextran 40 with albumin and Ringer's lactate as components of perfusion prime for cardiopulmonary bypass in patients undergoing myocardial revascularisation. Perfusion 1989; 4: 41-49.
2. Hoeft A, Korb H, Mehlhorn U et al. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: effect on colloid pressure and extravascular lung water. Br J Anaest 1991; 66: 73-80.
3. Sandrelli L, Alfieri O, van Oeveren W. The problem of priming solutions? The solution of priming problems. Perfusion 1992; 7: 217-21.
4. Kuitunen A, Hynynen M, Salmenpera M et al. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anesthesiol Scand 1993; 37: 652-58.
5. Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: plasma homeostasis, and renal function compared to use of 5% human albumin. Anesth Anal 1996; 83: 262-68.
6. Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G. The effect of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996; 83: 254-61.
7. Tigchelaar I, Gallandat Huet RCG, Korsten J, Boonstra PW, van Oeveren W. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg 1997; 11: 626-32.
8. Lee WH, Rubin JW, Huggins MP. Clinical evaluation of priming solutions for pump oxygenator perfusion. Ann Thorac Surg 1975; 19: 529-36.
9. Åberg M, Hedner U, Bergenetz SE. Effect of dextran on Factor VIII (antihemophilic factor) and platelet function. Ann Surg 1977; 189: 243-47.
10. Hässig A, Stampfli K. In: Lundsgaard-Hansen P, Hässig A and Nitschmann H eds. Modified gelatins as plasma substitutes. Basel: Karger, 1969: 1.
11. London MJ, Franks M, Verrier ED et al. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. J Thorac Cardiovasc Surg 1992; 104: 284-96.
12. Stump DC, Strauss RG, Henriksen A et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985; 25: 349-54.
13. Strauss RG, Stump DC, Henriksen A et al. Effects on hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 1985; 25: 230-33.
14. Palanzo DA, Parr GVS, Bull AP et al. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg 1982; 34: 680-83.
15. Sade RM, Crawford FA, Dearing JP et al. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1982; 84: 35-38.
16. Diehl JT, Lancelot Lester J, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982; 34: 674-79.
17. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularisation Ann Thorac Surg 1984; 37: 40-46.
18. Boldt J, Zickmann B, Ballesteros BM. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 1992; 74: 219-25.
19. Tabuchi N, de Haan J, Gallandat Huet RCG, Boonstra PW, van Oeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 1995; 74: 1447-51.
20. Lumb PD. A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass. Ann Thorac Surg 1987; 206: 210-13.
21. Sade RM, Stroud MR, Crawford MD et al. A prospective randomised study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 89: 713-22.
22. London MJ, Ho JS, Triedman JK et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989; 97: 785-97.
23. Schupbach P, Pappova E, Schilt W et al. Perfusate oncotic pressure during cardiopulmonary bypass: optimum level as determined by metabolic acidosis, tissue edema, and renal function. Vox Sang 1978; 35: 332-44.
24. Jansen PGM, te Velthuis H, Wildevuur CH et al. Cardiopulmonary bypass with modified gelatin and heparin-coated circuits. Br J Anaesth 1996; 76: 13-19.